Monday, June 30, 2025 6/30/2025

Nanobody-mediated proteolysis of Aspergillus fumigatus transcription factors in vitro and in vivo

Award Number: R21AI190747
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/24/2025
PERIOD OF PERFORMANCE END DATE: 01/31/2027

Group Awards By:

View Award Description

Nanobody-mediated proteolysis of Aspergillus fumigatus transcription factors in vitro and in vivo - Aspergillus fumigatus (Afu) is the primary human filamentous fungal pathogen and has been designated by the World Health Organization as one of the four most critical fungal pathogens impacting humans. The patient population at risk to Afu infections continues to rise owing to increased utilization of immune suppression for organ transplants, viral infections and cancer chemotherapy. While our need to understand the pathogenesis of aspergillosis is high, the experimental tools for genetics in Afu are limited. Most genetic approaches rely on changing the level of the gene of interest using disruption or overproduction strategies. Doxycycline-regulated promoter systems have also been used but these also only indirectly effect the level of the target protein by altering its mRNA production. Here we describe a new approach to analysis of the transcriptional control of virulence in Afu by regulated proteolysis of transcription factors already known to be important in pathogenesis. We have expressed an anti-GFP nanobody (GFPNb: single chain antibody from camelid species) fused to a mammalian E3 ligase enzyme (Rnf4) and found this fusion protein to trigger proteolysis of GFP fusion proteins in Afu. Expression of this fusion protein is under the control of a doxycycline-inducible promoter system allowing us to trigger protein degradation with the addition of doxycycline. We propose to accomplish two goals in this application. First, we will prepare GFP fusion proteins to 8 different transcription factors already known to be required for virulence when deleted from the cell. We will test all of these fusion proteins for localization, expression, phenotype and the ability to be degraded by the GFPNb-Rnf4 fusion protein. We will select up to 4 of these fusion proteins to test in a mouse infection model based on their retention of a normal in vitro phenotype and sensitivity to the GFPNb-Rnf4-mediated degradation. Immunosuppressed mice will be infected with these strains and then treated with doxycycline at different times to determine if the acute proteolytic removal of a factor of interest has an impact on fungal burden/survival. We will also confirm loss of a given factor after doxycycline treatment by western analysis of proteins from the mouse lung. This approach of directly degrading a transcription factor of interest, coupled with the ability to do this in a time-dependent manner, represents a fundamentally different means of interrogating the progression of mammalian infection by Afu.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $249,749 )
2025	2025	THE UNIVERSITY OF IOWA	105 JESSUP HALL	IOWA CITY	IA	52242	JOHNSON	USA	Allergy and Infectious Diseases Research	000	1	2/24/2025	NEW	$249,749
														Subtotal = $249,749

Grand Total All Awards = $249,749

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Nanobody-mediated proteolysis of Aspergillus fumigatus transcription factors in vitro and in vivo

Award Number: R21AI190747

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/24/2025

PERIOD OF PERFORMANCE END DATE: 01/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer